Sun BioPharma, Inc. Provides Business Update and Reports Q2 2020 Financial Results

NEXT STORY
Myovant Sciences Announces Corporate Updates and Financial Results for First Quarter Fiscal Year 2020
PREV STORY
Arcturus Therapeutics Announces that it has Initiated Dosing of its COVID-19 STARR™ mRNA Vaccine Candidate, LUNAR-COV19 (ARCT-021) in a Phase 1/2 study
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Enzymatica AB: Completing the Nomination Committee’s in Enzymatica AB proposal for AGM 2017 regarding election of auditor

Press ReleaseLund April 5, 2017                                                                                     Completing the Nomination Committee's in Enzymatica AB proposal ...

author_avatar
NASDAQ Market News

GENFIT to host a series of KOL Meetings in NASH

GENFIT to host a series of KOL Meetings in NASH Planned events will feature ...

author_avatar
NASDAQ Market News

Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

author_avatar
NASDAQ Market News